No Data
No Data
No Data
No Data
No Data
Cardiff Oncology Reveals Latest Cancer Research at AACR
TipRanksApr 8 16:23 ET
Cardiff Oncology Presents Novel Preclinical Data At AACR Annual Meeting 2024; Supports First-Line RAS-Mutated MCRC Clinical Study
– In RAS-mutated mCRC, novel preclinical finding demonstrates onvansertib inhibits the tumor's ability to adapt to hypoxia resulting in a significant decrease in both tumor vascularization and growth
BenzingaApr 8 16:06 ET
Cardiff Oncology (CRDF) Moves 20.5% Higher: Will This Strength Last?
Yahoo FinanceMar 14 08:08 ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersHeron Therapeutics (NASDAQ:HRTX) shares rose 35.4% to $3.19 during Wednesday's regular session. The market value of their outstanding shares is at $479.4 million. The company's, Q4 earnings cam
BenzingaMar 13 13:31 ET
ETRN, CRDF and KC Are Among Pre Market Gainers
Seeking AlphaMar 11 09:30 ET
Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2024
Globe NewswireMar 6 16:05 ET
No Data
No Data